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Immunological analysis, using the Pepscan technique, of the tetradecapeptide, ProWGlu357 (PLITHVLPFEKINE), from horse liver alcohol 
dehydrogenase has identified a five amino acid sequence, HVLPF, which binds a monoclonal antibody. The epitope seems to be rather flexible 
with only two of the amino acids, Pro and Phe, having the ch~~e~sti~ of contact residues. However, the presence of the adjacent glutamic acid 
residue as part of the Pepscan peptide has a dramatic negative neighbourhood effect and inhibits binding. This brights the potential risk of missing 
an epitope altogether when using the Pepscan procedure for epitope mapping. 
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1. INTRODUCTION 
We have previously characterised a monoclonal anti- 
body (MAb) against horse liver alcohol dehydrogenase 
(HADH). The MAb (mHADH1) was found to react 
preferentially to the enzyme bound to solid supports 
and to recognise the denatured and carboxymethylated 
HADH subunits. Immunological analysis of the frag- 
ments, obtained by proteolytic and chemical cleavage of 
the enzyme, led to the identification of a tetradecapep- 
tide (Pro3er_Glu3s7) which contains the epitope recogni- 
sed by the MAbs [I]. In keeping with this result the 
MAb was found to cross-react with the human Class I 
ADH isozymes (01, p, and y, coded at the ADH;, ADH, 
and ADH, loci) in which the sequence Pro3@-Glu357 is 
highly conserved [2]. 
The aim of the present investigation was to determine 
the minimum sequence recognised by the MAb and to 
identify the amino acids indispensable for binding. We 
have made use of the Pepscan method [3,4], which ena- 
bles the simultaneous ynthesis of a large number of 
short peptides on solid supports, to produce a series of 
overlapping peptides based on the sequence of the orig- 
inal tetradecapeptide. We have also carried out amino 
acid replacement analysis. Here we report the results of 
these studies and discuss some of the limitations of the 
Pepscan approach for epitope mapping. 
*Corresponding author. Fax: (39) (81) 593 6123. 
2. MATERIAL AND METHODS 
The peptides were synthesised in duplicate on pre-derivatised poly- 
ethylene pins by stepwise longation of the peptide chain from the C- 
to the N-terminus, according to the procedure described by Geysen 
et al. [4] using an Epitope Mapping Kit (Cambridge Research Bio- 
chemicals, Cambridge, UK). On completion of the synthesis the pep- 
tides were tested for their reactivity with the antibodies, by a modified 
ELISA procedure. The pins were blocked with 0.5% BSA in phos- 
phate-buffered saline (PBS) for 1 h at room temperature, and then 
incubated overnight at 4°C with the MAb diluted 1:500 in 0.25% BSA, 
0.05% Tween in PBS. This MAb concentration was chosen as being 
within the linear range of standard ELISA tests. Overnight incubation 
was required to obtain adequate signal with the pins. Horseradish 
peroxidase-conjugated rabbit anti-mouse immunoglobulins were used 
as the second antibody, and after 2 h at room temperature the pins 
were washed and the immunocomplexes detected using o-phenylenedi- 
amine as the substrate. As specificity controls the first antibody was 
omitted and/or culture supematants from the secreting myeloma line, 
P3/X63- Ag8, were used, also at 1:500, in place of the first antibody. 
The irnrn~o~ob~~ (IgG,) con~ntmtion of both mHADH, and 
P31x63 supematant was ea. 20 &ml, as determined by two-site 
ELISA on plates coated with 50 @/well of rabbit anti-mouse IgG (20 
,ug/ml) (ICN, USA) using mouse IgG, (Beckton Dickinson, USA) as 
the standard. Two tetrapeptides, Pro-Leu-Ala-Gln (PLAQ) and Gly- 
Leu-Ala-Ght (GLAQ), were synthesised as positive and negative con- 
trols, respectively, and tested using an anti-PLAQ MAb. The peptide- 
linked pins were washed free of bound antibodies in an ultrasonic bath 
as recommended by the manufacturer. 
3. RESULTS 
3.1. A~l~~~ of ov~r~~pp~g peptides and ident~~c~tion 
of the epitope 
Initially, a set of seven overlapping octapeptides, cov- 
ering the full sequence Pro344G1u357 (PLITHVLPFE- 
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Fig. 1. Immunoreactivity of mHADH1 with overlapping octapeptides 
from the sequence, Pro344-G1u357 of HADH. The immunoreactivity of
each overlapping octapeptide is expressed as absorbance at 492 nm. 
The results are reported as the means of two ELBA assays performed 
on duplicate pins (n = 4). The bar on each block represents the range 
of values obtained. 
KINE) was synthesised. The reaction of the MAb is 
shown in Fig. 1. The MAb recognised only one of these 
peptides, 346LITHVLPF 352 Neither the preceding nor . 
the following peptides showed significant binding. 
These results thus indicated that LITHVLPF comprised 
or contained the epitope. 
In order to identify residues that are critical for bind- 
ing, shorter peptides were synthesised by reducing the 
length of the sequence, LITHVLPF, from either end 
down to five amino acids. The results are shown in Fig. 
2. All the peptides containing the sequence, HVLPF, 
showed good binding, the most reactive being HVLPF 
on its own, suggesting that the epitope comprises these 
five amino acids. The results also suggested that Phe 
might be indispensable for the binding since a dramatic 
fall in reactivity was observed when this amino acid was 
removed from the sequence. However, it was not clear 
why the octapeptides, ITHVLPFE, THVLPFEK and - - 
HVLPFEKI, which all contained the immunoreactive 
sequence, failed to react (Fig. 1). To investigate whether 
the loss of reactivity was due to the presence of the Glu 
residue, we synthesised two further octapeptides in 
which Glu was substituted with Gln (uncharged with a 
bulky R group) and Gly (uncharged with a small R 
group). We also synthesised two further hexapeptides, 
HVLPFQ and HVLPFG, i.e. with the same substitu- 
tions. The results (Fig. 3) show that whenever Glu is 
present, reactivity is abolished. The presence of Gln or 
Gly does not abolish reactivity, although in each case 
the binding was lower than for ITHVLPF or HVLPF. 
Fig. 2. Effect of shortening the sequence of the peptide, LITHVLPF, 
on its immunoreactivity. The sequence was shortened from either end, 
as indicated beneath each bar, and the immunoreactivity and the 
results (n = 4) reported as in Fig. 1. 
3.2. Analysis of the specljkity of the reactivity of 
mHADH1 
To elucidate which amino acids were essential for 
binding the antibody, a series of pentapeptides was syn- 
thesised, in which single amino acid substitutions were 
made in the sequence, HVLPF. The substituted amino 
acids were chosen on the basis of their R group to 
represent ail the major classes, i.e. non polar, polar 
Fig. 3. Effect of the substitution of the glutamic acid on the reactivity 
of the epitope. The ELISA assay was performed on duplicate pins 
(n = 2) and the results expressed as percentage of the reactivity of the 
parent peptide, HVLPF. The bar on each block represents the range 
of the values obtained. 
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Fig. 4. Replacement set analysis of the epitope HVLPF. The position of the substituted amino acid is indicated by the asterisk in the parent peptide 
given beneath each block. The substituted amino acids are identified by the single letter code beneath each bar. (#) Parent peptide. The results 
of four ELBA assays performed on duplicate pins (n = 8) are expressed as the mean percentage of the reactivity of the parent peptide. The bar 
on each block represents the range of values obtained. 
uncharged and charged (Fig. 4). A number of the substi- 
tuted peptides, all of which end with Pro and Phe, were 
more reactive than the parent peptide. Substituting Pro 
and Phe led to a loss of reactivity except when Lys was 
substituted for either residue. His was somewhat less 
affected by replacement; Val and Leu could be replaced 
by many amino acids. 
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Fig. 5. Effect of deletion, elongation and inversion on the im- 
munoreactivity of HVLPF. The amino acid sequence of the peptides 
tested is shown beneath each bar. The ELISA assay was performed 
and the results (n = 2) expressed as in Fig, 3. 
It was of interest to determine whether the epitope 
retained its reactivity when the distance between His 
and Phe was altered and also when the sequence was 
reversed. Thus two peptides were synthesised, a hexa- 
peptide, which contained an additional Gly between 
Leu and Pro, and a tetrapeptide, in which the Leu was 
omitted. Both these peptides reacted with the MAb 
(Fig. 5). The epitope was also reactive when synthesised 
in the reverse orientation, FPLVH (Fig. 5). 
3.3. Analysis of analogous peptides from other alcohol 
We have compared the reactivity of HVLPF with that 
of analogous sequences present in other alcohol dehy- 
drogenases [2,5-91. The results are shown in Fig. 6. All 
the analogous synthetic peptides, with the possible ex- 
ception of ADHG, reacted with mHADH1. The lack of 
reactivity of the peptide from ADH6 is in agreement 
with the loss of reactivity observed when Pro and Phe 
were substituted with other amino acids. 
4. DISCUSSION 
In a previous study we localised an epitope recogni- 
sed by the anti-horse ADH monoclonal antibody, 
mHADH1, to the tetradecapeptide, Pro344-G1u357. In 
this paper we describe the use of the Pepscan system for 
the identification of the five amino acid sequence 
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Fig. 6. Immunoreactivity of the peptides equivalent to HVLPF present 
in the homologous sequence from several other alcohol dehydroge- 
nases. The amino acid sequence of each peptide is shown beneath and 
the corresponding dehydrogenase identified on top of each bar (ADH, 
human alcohol dehydrogenase isoenzymes; SDH, sorbitol dehydroge- 
nase). The ELISA assay was performed on duplicate pins (n = 2), and 
the results expressed as in Fig. 3. 
348HVLPF3s2 which is responsible for antibody binding. 
Whilst the identification of the pentapeptide epitope 
was unequivocal, it is noteworthy that three of the oc- 
tapeptides tested in the original screening, which con- 
tained the sequence, HVLPF, failed to react. This seems 
to be due to the presence of the glutamic acid adjacent 
to the phenylalanine. When either Gln or Gly were 
substituted for Glu at the C-terminal end of the octa- 
or hexapeptides containing HVLPF, the antibody bind- 
ing was largely restored. Interestingly this Glu residue 
does not appear to interfere with reactivity in the dena- 
tured ADH polypeptide or the tetradecapeptide, when 
bound to nitrocellulose [l]. Although other authors 
have commented on the variable effect of flanking 
amino acids on immunoreactivity in different experi- 
mental systems [lO-121, the dramatic negative neigh- 
bourhood effect observed in this case highlights the po- 
tential risk of missing an epitope altogether. 
Substitution analysis demonstrated that the most im- 
portant amino acids in the pentapeptide are Pro and 
Phe since they do not readily tolerate substitutions while 
all the other amino acids can. Furthermore, elongation 
(by insertion of Gly between Leu and Pro), deletion (by 
removal of Leu), and reversal of the pentapeptide se- 
quence are also very well tolerated. Thus it would ap- 
pear that in this case the requirements for antibody 
binding are rather flexible. The MAb does not react 
with ADH in solution even though the sequence, 
HVLPF, is located on the surface of the native dimeric 
molecule [13]. This result is consistent with the notion 
that Phe is a contact residue since in native ADH the 
Phe R group is buried with a measured accessibility of 
only 4% ([14], implementation by Simon Hubbard, Uni- 
versity College, London). 
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